183 related articles for article (PubMed ID: 16904788)
21. Economic aspects of antimicrobial therapy of acute exacerbations of COPD.
Simoens S; Decramer M; Laekeman G
Respir Med; 2007 Jan; 101(1):15-26. PubMed ID: 16650975
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
23. Assessing the costs of chronic obstructive pulmonary disease: the state medicaid perspective.
Marton JP; Boulanger L; Friedman M; Dixon D; Wilson J; Menzin J
Respir Med; 2006 Jun; 100(6):996-1005. PubMed ID: 16288858
[TBL] [Abstract][Full Text] [Related]
24. Substitutive "hospital at home" versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial.
Aimonino Ricauda N; Tibaldi V; Leff B; Scarafiotti C; Marinello R; Zanocchi M; Molaschi M
J Am Geriatr Soc; 2008 Mar; 56(3):493-500. PubMed ID: 18179503
[TBL] [Abstract][Full Text] [Related]
25. [Costs of the last hospitalization for patients with acute exacerbation of chronic obstructive pulmonary disease and patients with lung cancer].
Zhu ML; Cai BQ
Zhonghua Jie He He Hu Xi Za Zhi; 2009 Apr; 32(4):258-61. PubMed ID: 19576037
[TBL] [Abstract][Full Text] [Related]
26. COPD health care in Sweden - A study in primary and secondary care.
Löfdahl CG; Tilling B; Ekström T; Jörgensen L; Johansson G; Larsson K
Respir Med; 2010 Mar; 104(3):404-11. PubMed ID: 19963361
[TBL] [Abstract][Full Text] [Related]
27. Healthcare costs of COPD in Italian referral centres: a prospective study.
Koleva D; Motterlini N; Banfi P; Garattini L;
Respir Med; 2007 Nov; 101(11):2312-20. PubMed ID: 17681461
[TBL] [Abstract][Full Text] [Related]
28. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM
Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
[TBL] [Abstract][Full Text] [Related]
29. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
Akazawa M; Halpern R; Riedel AA; Stanford RH; Dalal A; Blanchette CM
Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
[TBL] [Abstract][Full Text] [Related]
30. [Active tobacco smoking as determinant of costs of inpatient treatment of COPD exacerbations].
Targowski T; Jahnz-Rózyk K; From S; Płusa T
Przegl Lek; 2004; 61(10):1049-51. PubMed ID: 15794248
[TBL] [Abstract][Full Text] [Related]
31. Improvement in COPD management by access to asthma/COPD clinics in primary care: data from the observational PATHOS study.
Lisspers K; Johansson G; Jansson C; Larsson K; Stratelis G; Hedegaard M; Ställberg B
Respir Med; 2014 Sep; 108(9):1345-54. PubMed ID: 25002194
[TBL] [Abstract][Full Text] [Related]
32. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination.
Menon B; Gurnani M; Aggarwal B
Int J Clin Pract; 2008 Apr; 62(4):593-8. PubMed ID: 18284444
[TBL] [Abstract][Full Text] [Related]
33. COPD: illness severity, resource utilisation and cost.
Tynan AJ; Lane SJ
Ir Med J; 2005 Feb; 98(2):41-2, 44-5. PubMed ID: 15835510
[TBL] [Abstract][Full Text] [Related]
34. Economic burden of chronic obstructive pulmonary disease.
Teo WS; Tan WS; Chong WF; Abisheganaden J; Lew YJ; Lim TK; Heng BH
Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
[TBL] [Abstract][Full Text] [Related]
35. An economic analysis of pharmacological treatment of COPD in Spain.
Miravitlles M; Brosa M; Velasco M; Crespo C; Gobartt E; Diaz S; González-Rojas N
Respir Med; 2009 May; 103(5):714-21. PubMed ID: 19168340
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of an intensive smoking cessation intervention for COPD outpatients.
Christenhusz LC; Prenger R; Pieterse ME; Seydel ER; van der Palen J
Nicotine Tob Res; 2012 Jun; 14(6):657-63. PubMed ID: 22180589
[TBL] [Abstract][Full Text] [Related]
37. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review.
Toy EL; Gallagher KF; Stanley EL; Swensen AR; Duh MS
COPD; 2010 Jun; 7(3):214-28. PubMed ID: 20486821
[TBL] [Abstract][Full Text] [Related]
38. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure.
Del Sindaco D; Pulignano G; Minardi G; Apostoli A; Guerrieri L; Rotoloni M; Petri G; Fabrizi L; Caroselli A; Venusti R; Chiantera A; Giulivi A; Giovannini E; Leggio F
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):324-9. PubMed ID: 17443097
[TBL] [Abstract][Full Text] [Related]
39. Effects of COPD self-care management education at a nurse-led primary health care clinic.
Efraimsson EO; Hillervik C; Ehrenberg A
Scand J Caring Sci; 2008 Jun; 22(2):178-85. PubMed ID: 18489687
[TBL] [Abstract][Full Text] [Related]
40. Analysis of predictive value of four risk models in Medicaid recipients with chronic obstructive pulmonary disease in Texas.
Yarger S; Rascati K; Lawson K; Barner J; Leslie R
Clin Ther; 2008; 30 Spec No():1051-7. PubMed ID: 18640479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
